HYDROCHLOROTHIAZIDE
- Product NDC
- 70934-916
- 11-digit product format
- 709340916
- Labeler code
- 70934
- Product ID
- 70934-916_d04d057b-14c9-0b99-e053-2995a90a8f2f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA085182
- Marketing category
- ANDA
- Marketing start
- 2021-10-28
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-916-30 | 70934091630 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-916-30) | 30 tablet | 2021-10-28 | 0000-00-00 | No | No | Current |
| 70934-916-90 | 70934091690 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-916-90) | 90 tablet | 2021-11-12 | 0000-00-00 | No | No | Current |